Pregnancy Registry in West China

Status Active, not recruiting

Clinical Trial Summary

With the Healthy China 2030 Plan for further reducing maternal mortality ratio (MMR), and increasing number of high-risk pregnancies in China, we aimed to develop a registry of pregnant women based on hospital-based Electronic Medical Records (EMR) data in West China, through integrating information technology and medical knowledge, by linking multi-resource data covering information regarding the whole cycle from pregnancy registration till delivery, and process of diagnosis, treatment and pregnancy outcomes, in order to provide reliable, valuable and efficient data resources for researches about high-risk pregnancy safety and MMR reduction in southwestern China. From January 29, 2014 to November 29, 2019, 64,468 pregnancies of 62,690 women were registered around gestational 13th weeks in the hospital, collecting over 47 million records (including repeated measurement data) from Health Information System (HIS), Laboratory Information System (LIS), and Picture Archiving and Communication System (PACS). After excluding 3476 pregnancies lost to follow-up and 7325 newly-pregnancies with expected date of delivery out of the study time, a total of 53,667 pregnancies about 51,964 women were finally included in the registry, who had been followed up till the occurrence of at least one outcome, including any pregnancy complication, abortion, stillbirth, induced labor, and live birth between January 1, 2015 and November 30, 2019. Till now, through data linkage, data collection, cleaning and recoding, we have generated more than 2100 structured variables regarding pre-pregnancy conditions, prenatal visit records, hospitalized diagnosis, treatment and discharge outcomes. The diagnoses of pregnancy complications, maternal and fetal outcomes, recorded by ICD-10 coding or free terms in original fields, were uniformly encoded by the Classification and Codes of Diseases released by Chinese National Standards Institute (GB/T14396-2016) and National Health Standard Criteria for Birth Defects (WS 377.6-2013).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Pregnant Women

Clinical Trial Details

NCT number	NCT04607499
Study type	Observational [Patient Registry]
Source	West China Hospital
Contact
Status	Active, not recruiting
Phase
Start date	January 2014
Completion date	December 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03955263` - Malaria In Pregnancy in Central India
Not yet recruiting	`NCT04457947` - Exploring Aromatherapy Intervention in Acute Care
Active, not recruiting	`NCT01397318` - Effects of Modified TaiChi Exercise on Maternal Stress, Fatigue, Sleep Quality, Biomarkers, and Infant Gestational Age and Birthweight	N/A
Completed	`NCT00639145` - Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
Not yet recruiting	`NCT00931099` - Fetal Outcome of Sleep Disordered Breathing During Pregnancy	N/A
Recruiting	`NCT00751569` - microRNA Profile in Umbilical Cord Blood NK Cells	N/A
Completed	`NCT06111716` - Mindfulness in Childbirth Preparation Education Process	N/A
Completed	`NCT05729191` - Evaluation of the Acceptance of the Anti-COVID-19 Vaccine Offer Among Pregnant Women
Completed	`NCT01687634` - Home Visiting for Low Income, Pregnant Women	N/A
Recruiting	`NCT05446571` - Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Versus Valaciclovir	Phase 3
Not yet recruiting	`NCT03651934` - Verification of Correlation Between Genetic Testing of Nutritional Metabolism and Clinical Biochemical Indicators	N/A
Completed	`NCT02904473` - Goals for Reaching Optimum Wellness (GROWell)	N/A
Completed	`NCT03538106` - Factors Associated With Cesarean Delivery in Women With Type 1 Diabetes
Recruiting	`NCT01246765` - National Pregnancy Registry for Psychiatric Medications
Completed	`NCT00553228` - Pertussis Maternal Immunization Study	Phase 2/Phase 3
Recruiting	`NCT05916534` - We Care About Brooklyn - A Digital Behavioral Intervention to Optimize Engagement in Maternal Healthcare	N/A
Completed	`NCT04264910` - CALM Pregnancy: Feasibility of Calm for Pregnant Women	N/A
Completed	`NCT04494581` - GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region
Recruiting	`NCT05349279` - Qatar PREgnancy Covid-19 OUtcome Study
Withdrawn	`NCT04354441` - Effect of Hydroxychloroquine in COVID-19 Positive Pregnant Women	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.